Complete Response to Clofarabine Is Durable and Correlates with Survival in Previously Untreated Older Adult Patients with Acute Myeloid Leukemia (AML) and Unfavorable Prognostic Factors
Publication
, Conference
Gabrilove, J; Faderl, S; Erba, HP; Claxton, DF; Arellano, M; Lyons, RM; Kovacsovics, TJ; Eckert, S; Huebner, D; Kantarjian, HM
Published in: BLOOD
November 20, 2009
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 20, 2009
Volume
114
Issue
22
Start / End Page
814 / 814
Location
New Orleans, LA
Publisher
AMER SOC HEMATOLOGY
Conference Name
51st Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Gabrilove, J., Faderl, S., Erba, H. P., Claxton, D. F., Arellano, M., Lyons, R. M., … Kantarjian, H. M. (2009). Complete Response to Clofarabine Is Durable and Correlates with Survival in Previously Untreated Older Adult Patients with Acute Myeloid Leukemia (AML) and Unfavorable Prognostic Factors. In BLOOD (Vol. 114, pp. 814–814). New Orleans, LA: AMER SOC HEMATOLOGY.
Gabrilove, Janice, Stefan Faderl, Harry P. Erba, David F. Claxton, M. Arellano, Roger M. Lyons, Tibor J. Kovacsovics, Stephen Eckert, Dirk Huebner, and Hagop M. Kantarjian. “Complete Response to Clofarabine Is Durable and Correlates with Survival in Previously Untreated Older Adult Patients with Acute Myeloid Leukemia (AML) and Unfavorable Prognostic Factors.” In BLOOD, 114:814–814. AMER SOC HEMATOLOGY, 2009.
Gabrilove J, Faderl S, Erba HP, Claxton DF, Arellano M, Lyons RM, et al. Complete Response to Clofarabine Is Durable and Correlates with Survival in Previously Untreated Older Adult Patients with Acute Myeloid Leukemia (AML) and Unfavorable Prognostic Factors. In: BLOOD. AMER SOC HEMATOLOGY; 2009. p. 814–814.
Gabrilove, Janice, et al. “Complete Response to Clofarabine Is Durable and Correlates with Survival in Previously Untreated Older Adult Patients with Acute Myeloid Leukemia (AML) and Unfavorable Prognostic Factors.” BLOOD, vol. 114, no. 22, AMER SOC HEMATOLOGY, 2009, pp. 814–814.
Gabrilove J, Faderl S, Erba HP, Claxton DF, Arellano M, Lyons RM, Kovacsovics TJ, Eckert S, Huebner D, Kantarjian HM. Complete Response to Clofarabine Is Durable and Correlates with Survival in Previously Untreated Older Adult Patients with Acute Myeloid Leukemia (AML) and Unfavorable Prognostic Factors. BLOOD. AMER SOC HEMATOLOGY; 2009. p. 814–814.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 20, 2009
Volume
114
Issue
22
Start / End Page
814 / 814
Location
New Orleans, LA
Publisher
AMER SOC HEMATOLOGY
Conference Name
51st Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology